Literature DB >> 15570974

High-resolution and analytical TEM investigation of metastable-tetragonal phase stabilization in undoped nanocrystalline zirconia.

Vladimir P Oleshko1, James M Howe, Satyajit Shukla, Sudipta Seal.   

Abstract

Submicron and nano-sized nanocrystalline pure zirconia (ZrO2) powders having metastable tetragonal and tetragonal-plus-monoclinic crystal structures, respectively, were synthesized using the sol-gel technique. The as-precipitated and the calcinated ZrO2 powders were analyzed for their morphology, nanocrystallite size and structures, aggregation tendency, local electronic properties, and elemental compositions by conventional and high-resolution transmission electron microscopy and field-emission analytical electron microscopy, including energy-dispersive X-ray and electron energy-loss spectroscopies. The results from this study indicate that a combination of nanocrystallite size, strain-induced grain-growth confinement, and the simultaneous presence of the monoclinic phase can lead to stabilization of the metastable tetragonal-phase in undoped ZrO2. As a result, the tetragonal phase is stabilized within ZrO2 nanocrystallites up to 100 nm in size, which is 16 times larger than the previously reported critical size of 6 nm.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15570974     DOI: 10.1166/jnn.2004.110

Source DB:  PubMed          Journal:  J Nanosci Nanotechnol        ISSN: 1533-4880


  2 in total

1.  Hydrogen Surface Reactions and Adsorption Studied on Y2O3, YSZ, and ZrO2.

Authors:  Michaela Kogler; Eva-Maria Köck; Thomas Bielz; Kristian Pfaller; Bernhard Klötzer; Daniela Schmidmair; Lukas Perfler; Simon Penner
Journal:  J Phys Chem C Nanomater Interfaces       Date:  2014-04-02       Impact factor: 4.126

2.  Sensitization of pancreatic cancer cells to radiation by cerium oxide nanoparticle-induced ROS production.

Authors:  Melissa S Wason; Jimmie Colon; Soumen Das; Sudipta Seal; James Turkson; Jihe Zhao; Cheryl H Baker
Journal:  Nanomedicine       Date:  2012-11-22       Impact factor: 5.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.